Sanoculis
PrivateLast Round
Series C
Jul 28, 2022
Est. Valuation
$49M
Total Funding Raised
$23M
Company Overview
Sanoculis Ltd. is a privately held medical device company based in Kiryat Ono, Israel, that specializes in developing innovative and minimally invasive surgical solutions for glaucoma. Founded in 2012, the company's primary products are the Minimally Invasive Micro Sclerostomy (MIMS) and the Minimally Invasive Nasal Trabeculostomy (MINT), which are stent-free procedures designed to reduce intraocular pressure in glaucoma patients. The company is actively operating and received CE Mark approval for its MINT product in April 2025, with plans for a commercial launch. Sanoculis has entered into strategic agreements, including a European distribution deal with Bausch + Lomb, to expand its market presence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanoculis Comps
Public and private peers based on sector, stage, and business model.
Sanoculis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 28, 2022 | ||||
| Series B | Sep 11, 2019 |
Sanoculis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Infinity Group | Series C |
| Eckuity | Series C |
| HCS Capital Partners | Series B |
Sanoculis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sanoculis's valuation, stock price, and market status.
